|HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells|
MR Betts, MC Nason, SM West, SC De Rosa, SA Migueles, J Abraham, ...
Blood 107 (12), 4781-4789, 2006
|Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection|
BF Keele, EE Giorgi, JF Salazar-Gonzalez, JM Decker, KT Pham, ...
Proceedings of the National Academy of Sciences 105 (21), 7552-7557, 2008
|Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies|
M Li, F Gao, JR Mascola, L Stamatatos, VR Polonis, M Koutsoukos, ...
Journal of virology 79 (16), 10108-10125, 2005
|Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry|
PK Chattopadhyay, DA Price, TF Harper, MR Betts, J Yu, E Gostick, ...
Nature medicine 12 (8), 972-977, 2006
|Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma|
BH Edwards, A Bansal, S Sabbaj, J Bakari, MJ Mulligan, PA Goepfert
Journal of virology 76 (5), 2298-2305, 2002
|Perforin expression directly ex vivo by HIV-specific CD8+ T-cells is a correlate of HIV elite control|
AR Hersperger, F Pereyra, M Nason, K Demers, P Sheth, LY Shin, ...
PLoS Pathog 6 (5), e1000917, 2010
|Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A|
MA Brockman, A Schneidewind, M Lahaie, A Schmidt, T Miura, I DeSouza, ...
Journal of virology 81 (22), 12608-12618, 2007
|Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B* 5703-restricted Gag epitope in chronic human …|
H Crawford, JG Prado, A Leslie, S Hué, I Honeyborne, S Reddy, ...
Journal of virology 81 (15), 8346-8351, 2007
|Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients|
PA Goepfert, W Lumm, P Farmer, P Matthews, A Prendergast, JM Carlson, ...
The Journal of experimental medicine 205 (5), 1009-1017, 2008
|A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon|
PA Goepfert, A Bansal, BH Edwards, GD Ritter, I Tellez, SA McPherson, ...
Journal of virology 74 (21), 10249-10255, 2000
|Selection bias at the heterosexual HIV-1 transmission bottleneck|
JM Carlson, M Schaefer, DC Monaco, R Batorsky, DT Claiborne, J Prince, ...
Science 345 (6193), 2014
|Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated|
HX Liao, X Chen, S Munshaw, R Zhang, DJ Marshall, N Vandergrift, ...
Journal of Experimental Medicine 208 (11), 2237-2249, 2011
|Modeling sequence evolution in acute HIV-1 infection|
HY Lee, EE Giorgi, BF Keele, B Gaschen, GS Athreya, ...
Journal of theoretical biology 261 (2), 341-360, 2009
|Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection|
MC Levesque, MA Moody, KK Hwang, DJ Marshall, JF Whitesides, ...
PLoS Med 6 (7), e1000107, 2009
|Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway|
NL Bowers, ES Helton, RPH Huijbregts, PA Goepfert, SL Heath, Z Hel
PLoS Pathog 10 (3), e1003993, 2014
|Evolution of HLA-B* 5703 HIV-1 escape mutations in HLA-B* 5703–positive individuals and their transmission recipients|
H Crawford, W Lumm, A Leslie, M Schaefer, D Boeras, JG Prado, J Tang, ...
Journal of Experimental Medicine 206 (4), 909-921, 2009
|Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection|
MR Betts, B Exley, DA Price, A Bansal, ZT Camacho, V Teaberry, ...
Proceedings of the National Academy of Sciences 102 (12), 4512-4517, 2005
|Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help|
MJ Fuller, DA Hildeman, S Sabbaj, DE Gaddis, AE Tebo, L Shang, ...
The Journal of Immunology 174 (10), 5926-5930, 2005
|Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles|
PA Goepfert, ML Elizaga, A Sato, L Qin, M Cardinali, CM Hay, J Hural, ...
Journal of Infectious Diseases 203 (5), 610-619, 2011
|A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)|
GJ Churchyard, C Morgan, E Adams, J Hural, BS Graham, Z Moodie, ...
PloS one 6 (8), e21225, 2011